FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
The U.S. Food and Drug Administration on Monday asked a Washington court to throw out a suit by Mylan Pharmaceuticals Inc. seeking to force the agency to strip Ranbaxy Laboratories Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article